M3 Inc. an online platform for medical professionals based in Japan, has acquired a majority stake in Bengaluru-based Neuroglia Health Private Limited (NHPL), a provider of mobile and web-based applications for doctors and medical students. The amount is yet to be disclosed.
Neuroglia Health owns and operates “DailyRounds” mobile app, which enables case-based problem-solving for doctors.
“With this majority acquisition, M3 India will now be able to reach out to 450,000 doctors in India on a consolidated basis, while enhancing the utility and satisfaction levels among Doctors by leveraging the strengths of both platforms. It will also enable M3 India to escalate its marketing support and market research businesses to pharmaceutical and medical devices,” said Amit Singh, chief executive of HIPL in a statement.
“We are very excited with this development. With the support of M3 we will be offer better services to the existing doctors. Further, we hope to bring in new doctors as well. The goal is to be largest doctor network in India, not just by registered numbers, but in terms of active users as well,” added Dr. Deepu Sebin, chief executive of Neuroglia Health.
M3 will import services and technology to India and work on the expansion.